** Shares of Nyrada NYR.AX fall as much as 10.7% to
A$0.125, their biggest intraday percentage loss since early
October
** Shares hit their lowest level since Oct. 21
** The pharma co says it has raised about A$3.4 million
($2.25 million) by way of a placement
** Issue price of A$0.12 per share is at a 14.3% discount to
last close on Oct. 23
** Says funds to be used primarily for completion of Phase
I(a) clinical trial and Investigational New Drug applications
with the U.S. Food and Drug Administration
** Stock up 536.4% YTD as at 2315 GMT
($1 = 1.5133 Australian dollars)
(Reporting by Echha Jain in Bengaluru; Editing by Lisa
Shumaker)
((Echha.jain@thomsonreuters.com))